Trials / Completed
CompletedNCT02249442
Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency
An Open-label Study to Determine the Pharmacokinetics of Single-dose and/or Steady-state TPV/r 500/200 mg in Subjects With Mild and Moderate Hepatic Insufficiency
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To determine the pharmacokinetics of single-dose and steady-state Tipranavir/Ritonavir (TPV/r) 500/200 mg in subjects with mild to moderate hepatic insufficiency
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tipranavir (TPV) | |
| DRUG | Ritonavir (r) |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2004-06-01
- First posted
- 2014-09-25
- Last updated
- 2025-01-23
Source: ClinicalTrials.gov record NCT02249442. Inclusion in this directory is not an endorsement.